Detailed Breakdown of Neurosurgery Costs at Sanbo Brain Hospital
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
Based on the information I have collected, I can provide you with the following detailed information regarding neurosurgery costs at Sanbo Brain Hospital:
According to information on the official website of Sanbo Brain Hospital, pituitary tumor surgery is a representative neurosurgical procedure, and its cost varies depending on the surgical method[1]:
- Craniotomy for Microsurgical Pituitary Tumor Resection: Cost is approximatelyRMB 80,000
- Transsphenoidal Pituitary Tumor Resection: Cost is approximatelyRMB 40,000
It should be noted that if the patient’s condition is severe, with preoperative hydrocephalus, poor physical condition, or multiple complications, the cost may increase slightly. Charges also vary across different regions and hospitals.
According to data from Sanbo Brain Hospital’s prospectus and brokerage research reports[2]:
| Per Capita Expense Range | Patient Proportion | Revenue Contribution |
|---|---|---|
| RMB 30,000 or below | 76% | 22% |
| RMB 60,000 or above | 16% | 67% |
This indicates that although most patients (76%) have per capita expenses below RMB 30,000, high-spending patients (with per capita expenses of RMB 60,000 or above), despite accounting for only 16% of patients, contribute 67% of the revenue, suggesting a certain proportion of complex, high-difficulty surgeries.
- Surgeries Performed: 4,071 cases(all neurosurgeries)
- Inpatient Admissions: 10,156 people
- Bed Utilization Rate: 94%
- Annual Output per Bed: RMB 1.8 million
- Average Number of Surgeries per Physician: 58.2 cases(all neurosurgeries)
2022 financial data of Sanbo Brain Hospital Management Group:
- Medical Service Revenue: RMB 811 million (accounting for 76.18%)
- Pharmaceutical Sales Revenue: RMB 254 million (accounting for 23.82%)
-
Transparent Pricing: Fujian Sanbo Funeng Brain Hospital posts price lists for various medical services such as surgeries and examinations in elevators, corridors, consulting rooms, etc., allowing patients to compare costs with other Grade A tertiary hospitals in the province at any time[3].
-
Reasonable Charges: Sanbo Brain Hospital adheres to a reasonable charging structure, minimizing the proportion of charges for pharmaceuticals and medical consumables, and is committed to providing medical services with “excellent technology, good service, and low prices”[3].
-
Medical Insurance Coverage: All hospitals under the group have obtained designated medical insurance qualification. Basic medical services are priced in accordance with medical insurance regulations, while some medical services have independent pricing rights.
The average cost of neurosurgery at Sanbo Brain Hospital varies significantly depending on the type of surgery and the complexity of the patient’s condition. Simple surgeries cost approximately RMB 30,000 to 40,000, while complex surgeries can cost RMB 60,000 to 80,000 or even more. The overall per capita inpatient expense of the hospital is mainly concentrated in the range below RMB 30,000, but the cost of high-difficulty surgeries is significantly higher. Due to the particularity of medical services, the specific cost needs to be determined based on the patient’s specific condition and treatment plan.
[1] Official Website of Beijing Sanbo Brain Hospital - Explanation on Pituitary Tumor Surgery Costs (https://m.sbnk.cn/show-11544.html)
[2] Northeast Securities - New Stock Research Report on Sanbo Brain Hospital (301293.SZ) (https://www.nesc.cn/timerfiles/upload/report/2024/01/18/15813646.pdf)
[3] Introduction to Fujian Sanbo Funeng Brain Hospital (https://m.sbfnnk.com/view.php?aid=1049)
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
